Table 5.

Statistical analysis per treatment site for a six‐month period (June 2013 to January 2014).

Site	Controls Number	Beams Number	Mean Dose Difference	SD	Tolerance Levels
Breast ‐ supine	3882	1342	2.2%	4.5 %	7.5%
Axillary	2804	967	0.5%	4.9%	7.5%
Metastasis	2630	991	1.8%	3.9%	7.1%
Breast ‐ lateral	2508	833	0.8%	3.1%	6.7%
Internal mammary lymph nodes	401	140	1.9%	8.4%	10.0%
Limb	192	85	$-1.2\%$	5.0%	8.2%
Thorax	189	62	$-1.1\%$	6.3%	7.5%
Ophthalmology	94	38	0.1%	5.0%	8.7%
Neck & Oral	145	51	$-2.2\%$	5.4%	7.5%
Pelvis	125	30	$-1.8\%$	4.9%	8.0%
Head	65	17	$-1.8\%$	5.4%	7.5%